Project description

MOV-malunggay organic vaccine

In order to solve the various problems caused by the epidemic, we will invent malunggay soluble vaccine, which is
a simple technology for preparing instant dissolving tablets. The materials required for this vaccine are as follows:
Malunggay, starch emulsion, phospholipid emulsion paste .
And the first thing we need to do is to sieved The starch emulsion, and then mix the paste, then add the liquid
with the phospholipid emulsion to make the paste, and then the steam insulation and film making process are
carried out, and finally cut it into pieces according to a certain proportion of the vaccine to make dissolving
tablets.

Significant dates
In March: We will start collecting materials to make vaccines.
In April: We will start our vaccine development phase, and we will take animal experiments to verify the feasibility
of the vaccine.
From May to June: We will improve the vaccine so that the body can use the vaccine, and in the process we will
recruit volunteers to prepare for the first phase of clinical trials.
In July: We will observe the safety and response of the vaccine in the human body after injecting the vaccine
against a small number of lower-risk humans, and also collect the human immune response to the vaccine.
In August: After we pass the first phase, we will begin to need more funding to evaluate vaccines for different
ages, races, genders and other ethnic groups to improve the safety and effectiveness of vaccines.
In September: In this third phase, we mainly focus on experiments with a scale of thousands of people or more
to evaluate the time to market for vaccines, evaluate the increased immunity of vaccines in humans, and vaccine
efficacy. When it is high enough, manufacturers may develop vaccines. The unit organization can apply to the
regulatory authority for patent preparation for listing.
In October: In the fourth phase, after the vaccine was launched, we still continued to improve the vaccine based
on its usage and human response.

Sponsorship
We will accept all sponsorships for the use and development of vaccines, and make the flow of funds transparent.
At the same time, our sponsors will get the vaccine for them as soon as the finished product is developed.
Time line
MOV-malunggay organic vaccine
Collecting the materials needed for
March 1-15
vaccine and prepare the equipment that
is needed
Conduct an inspection to confirm that
March 16-20
there is no problem in the production
workshop and that the work place and
environment are safe
Start to develop vaccine, and prepare
April 1-10
animals for the upcoming Animal
experiment
Observe the animal’s reaction and make
April 10-30
records of it every day
Make sure if there is no negative effect of
May 1-5
using vaccine for the animal, and write
down the observation of experiment and
Apply for the next phase of the
experiment
Improve the vaccine, make sure that the
May 6 - june 15
body can use the vaccine, get the apply
for the next phase of experiment and
find volunteers want to join for the
experiment
Start the experiment of vaccine in the
July 1
human body

observe the reaction and feeling of the

July 2 - July 20
volunteers and record

Finalize and make conclusion of the

July 21 - July 31
observation, and waiting for the apply of
next stage experiment of vaccine
Find volunteers that have different age,
August 1 - 3
race, sex for the next stage

Start the experiment and observe the

August 4 - 20
reaction and feeling of the volunteers
and record
Make sure the safety and efficiency of
August 21 - 31
vaccine and apply for the next stage
experiment for the vaccine;’ find
thousand of volunteer for the next stage
 Start the experiment and observe all the
September 1 - 15
reaction and feeling of volunteers;
evaluate the time to market for vaccines,
evaluate the increased immunity of
vaccines in humans, and vaccine efficacy.
Manufacturers are preparing to develop
September 16 - 25
vaccines, apply for patents and prepare
for the market
The vaccine will put on the market, we
October 1 - 25
will observe the use of the vaccine and
the reaction of people to improve the
vaccine